¼¼°èÀÇ Á½ɹæÀÌ Æó»ö ±â±â ½ÃÀå Á¶»ç º¸°í¼ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2033³â)
Global Left Atrial Appendage Closure Device Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
»óǰÄÚµå
:
1683261
¸®¼Ä¡»ç
:
Value Market Research
¹ßÇàÀÏ
:
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 125 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¼¼°èÀÇ Á½ɹæÀÌ Æó»ö ±â±â ½ÃÀå ±Ô¸ð´Â 2024³â 27¾ï ´Þ·¯¿¡¼ 2033³â¿¡´Â 138¾ï ´Þ·¯·Î ¼ºÀåÇϸç, 2026-2033³âÀÇ ¿¹Ãø ±â°£ Áß 19.87%ÀÇ °ß°íÇÑ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
½É¹æ¼¼µ¿(AF) À¯º´·ü Áõ°¡¿Í È¿°úÀûÀÎ ³úÁ¹Áß ¿¹¹æ Àü·«¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¼¼°è ÁÂ½É¹æ ºÎ¼Ó±â(LAA) Æó¼âÀåºñ ½ÃÀåÀº Å« ÆøÀÇ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³úÁ¹Áß À§ÇèÀ» °¨¼Ò½Ã۵µ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ÀÇ·áÁøÀÌ È¯ÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí Ç×ÀÀ°í Ä¡·á¿Í °ü·ÃµÈ ÇÕº´ÁõÀ» ÃÖ¼ÒÈÇϱâ À§ÇØ ³ë·ÂÇÔ¿¡ µû¶ó LAA Æó¼âÀåºñÀÇ Ã¤ÅÃÀÌ Å©°Ô Áõ°¡ÇÏ¿© ÀÌ Àü¹® ½ÃÀå¿¡ ´ëÇÑ Çõ½Å°ú ÅõÀÚ¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¶ÇÇÑ Àåºñ ±â¼ú ¹× ½Ã¼úÀÇ ¹ßÀüÀº ½ÃÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àúħ½ÀÀû LAA Æó¼â Àåºñ¿Í °³¼±µÈ Àü´Þ ½Ã½ºÅÛÀÇ °³¹ß·Î ½Ã¼úÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀÌ Çâ»óµÇ¾î ´õ ¸¹Àº ȯÀÚµéÀÌ ½Ã¼ú¿¡ Á¢±ÙÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ °æ½Äµµ ½ÉÃÊÀ½ÆÄ µî ¿µ»ó ±â¼úÀÇ ÅëÇÕÀ¸·Î ½Ã¼ú Áöħ°ú Ä¡·á °á°ú°¡ °³¼±µÇ°í ÀÖ½À´Ï´Ù. ȯÀÚ Áß½ÉÀÇ Ä¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¾ÈÀü¼º°ú Àå±âÀû À¯È¿¼ºÀ» °³¼±ÇÑ Çõ½ÅÀûÀÎ LAA Æó¼â¼ú¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¶ÇÇÑ ³úÁ¹Áß ¿¹¹æ¿¡ ´ëÇÑ °Á¶¿Í ½É¹æ¼¼µ¿¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó LAA Æó¼âÀåºñ ½ÃÀåÀÇ ¹Ì·¡°¡ Çü¼ºµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ȯÀÚµéÀÌ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ Áö½ÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½É¹æ¼¼µ¿°ú °ü·ÃµÈ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ´Â È¿°úÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á±â±â Á¦Á¶¾÷ü, ½ÉÀå Àü¹®ÀÇ, ÀÇ·á ±â°ü °£ÀÇ Çù·ÂÀº LAA Æó¼â Àåºñ ½ÃÀåÀÌ ½ÉÇ÷°ü Çõ½ÅÀÇ ÃÖÀü¼±¿¡ ¼¼ ÀÌ·¯ÇÑ ¹ßÀüÀ» ÃËÁøÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.
´ç»çÀÇ º¸°í¼´Â °í°´¿¡°Ô ´Ù¾çÇÑ »ê¾÷ ¹× ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÌ°í ½Ç¿ëÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇϱâ À§ÇØ ¼¼½ÉÇÏ°Ô ÀÛ¼ºµÇ¾ú½À´Ï´Ù. °¢ º¸°í¼¿¡´Â ½ÃÀå »óȲÀ» ¿ÏÀüÈ÷ ÀÌÇØÇϱâ À§ÇÑ ¸î °¡Áö Áß¿äÇÑ ¿ä¼Ò°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.
½ÃÀå °³¿ä : Á¤ÀÇ, ºÐ·ù, »ê¾÷ ÇöȲ µî ½ÃÀå¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ¼Ò°³.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ : ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× °úÁ¦¸¦ »ó¼¼ÇÏ°Ô ºÐ¼®ÇÕ´Ï´Ù. ÀÌ ¼½¼Ç¿¡¼´Â ±â¼ú ¹ßÀü, ±ÔÁ¦ º¯È, »õ·Î¿î µ¿Çâ µîÀÇ ¿äÀÎÀ» °ËÅäÇÕ´Ï´Ù.
¼¼ºÐÈ ºÐ¼® : Á¦Ç° À¯Çü, ¾ÖÇø®ÄÉÀ̼Ç, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ª µîÀÇ ±âÁØ¿¡ µû¶ó ½ÃÀåÀ» ¸íÈ®ÇÑ ºÎ¹®À¸·Î ºÐ·ùÇÕ´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ °¢ ºÎ¹®ÀÇ ¼º°ú¿Í ÀáÀç·ÂÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.
°æÀï»óȲ : ½ÃÀå Á¡À¯À², Á¦Ç° Æ÷Æ®Æú¸®¿À, Àü·«Àû ±¸»ó, À繫½ÇÀû µî ÁÖ¿ä ½ÃÀå ÁøÀÔ±â¾÷¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Æò°¡. ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇϰí ÀÖ´Â °æÀï ¿ªÇÐ ¹× ÁÖ¿ä Àü·«¿¡ ´ëÇÑ ÀλçÀÌÆ®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.
½ÃÀå ¿¹Ãø : °ú°Å µ¥ÀÌÅÍ¿Í ÇöÀç ½ÃÀå »óȲÀ» ¹ÙÅÁÀ¸·Î ÀÏÁ¤ ±â°£ Áß ½ÃÀå ±Ô¸ð¿Í ¼ºÀå Ãß¼¼¸¦ ¿¹ÃøÇÕ´Ï´Ù. ¿©±â¿¡´Â Á¤·®Àû ºÐ¼®°ú ¹Ì·¡ ½ÃÀå ±ËÀûÀ» ³ªÅ¸³»´Â ±×·¡ÇÁ Ç¥½Ã°¡ Æ÷ÇԵ˴ϴÙ.
Áö¿ª ºÐ¼® : Áö¿ªº° ½ÃÀå ¼º°ú¸¦ Æò°¡Çϰí ÁÖ¿ä ½ÃÀå ¹× Áö¿ª µ¿ÇâÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. Áö¿ª ½ÃÀå ¿ªÇÐ ¹× ºñÁî´Ï½º ±âȸ¸¦ ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.
»õ·Î¿î µ¿Çâ°ú ±âȸ : ÇöÀç ½ÃÀå µ¿Çâ°ú »õ·Î¿î ½ÃÀå µ¿Çâ, ±â¼ú Çõ½Å, ÀáÀçÀû ÅõÀÚ ´ë»ó ºÎ¹®À» ½Äº°ÇÕ´Ï´Ù. ¹Ì·¡ ½ÃÀå °³¹ß ¹× ¼ºÀå Àü¸Á¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼¹®
Á¦2Àå °³¿ä
- ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
- ¼¼°è ½ÃÀå ½º³À¼ô
Á¦3Àå Á½ɹæÀÌ Æó»ö ±â±â »ê¾÷ ºÐ¼®
- ¼·Ð : ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ½ÃÀå ±âȸ
- »ê¾÷ µ¿Çâ
- Porter's Five Forces ºÐ¼®
- ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®
- ¹ë·ùüÀÎ ºÐ¼®
- ¿ø·á ºÐ¼®
- ¿ø·á ¸®½ºÆ®
- ¿ø·á Á¦Á¶¾÷ü ¸®½ºÆ®
- ÁÖ¿ä ¿ø·áÀÇ °¡°Ý µ¿Çâ
- ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
- ¸¶ÄÉÆÃ Ã¤³Î
- Á÷Á¢ ¸¶ÄÉÆÃ
- °£Á¢ ¸¶ÄÉÆÃ
- ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ
Á¦5Àå ¼¼°èÀÇ Á½ɹæÀÌ Æó»ö ±â±â ½ÃÀå ºÐ¼® : Á¦Ç°º°
- Á¦Ç°º° °³¿ä
- Á¦Ç°º° °ú°Å¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
- ½É³»¸·Çü LAA ±â±â
- ½É¿Ü¸· LAA ±â±â
Á¦6Àå ¼¼°èÀÇ Á½ɹæÀÌ Æó»ö ±â±â ½ÃÀå ºÐ¼® : ½Ã¼úº°
- ½Ã¼úº° °³¿ä
- ½Ã¼úº° °ú°Å¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
- °æÇÇÀû
- ¿Ü°úÀû
Á¦7Àå ¼¼°èÀÇ Á½ɹæÀÌ Æó»ö ±â±â ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°
- ÃÖÁ¾ ¿ëµµº° °³¿ä
- ÃÖÁ¾ ¿ëµµº° °ú°Å¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
- º´¿ø
- ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
- ±âŸ
Á¦8Àå ¼¼°èÀÇ Á½ɹæÀÌ Æó»ö ±â±â ½ÃÀå ºÐ¼® : Áö¿ªº°
- Áö¿ªº° Àü¸Á
- ¼·Ð
- ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- ºÏ¹Ì : ºÎ¹®º°
- ºÏ¹Ì : ±¹°¡º°
- ¹Ì±¹
- ij³ª´Ù
- ¸ß½ÃÄÚ
- À¯·´ ÆÇ¸Å ºÐ¼®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- À¯·´ : ºÎ¹®º°
- À¯·´ : ±¹°¡º°
- ¿µ±¹
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç ÆÇ¸Å ºÐ¼®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
- Áß±¹
- Àεµ
- ÀϺ»
- Çѱ¹
- È£ÁÖ
- µ¿³²¾Æ½Ã¾Æ
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä« ÆÇ¸Å ºÐ¼®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
- ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- Æä·ç
- Ä¥·¹
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆÇ¸Å ºÐ¼®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° ¸®½ºÆ®
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- À̽º¶ó¿¤
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦9Àå Á½ɹæÀÌ Æó»ö ±â±â ±â¾÷ÀÇ °æÀï ±¸µµ
- Á½ɹæÀÌ Æó»ö ±â±â ½ÃÀå °æÀï
- Á¦ÈÞ/Çù¾÷/ÇÕÀÇ
- ÇÕº´¡¤Àμö
- ½ÅÁ¦Ç° ¹ß¸Å
- ±âŸ °³¹ß
Á¦10Àå ±â¾÷ °³¿ä
- »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
- ½ÃÀå ÁýÁßµµ
- Abbott Laboratories
- AtriCure
- Boston Scientific Corporation
- Lepu Medical Technology
- LifeTech Scientific
- MicroPort Scientific Corporation
- Nanjing YDB Technology
- Shanghai Push Medical Device Technology
- Biosense Webster Inc.
- Aegis Medical Group
KSA
¿µ¹® ¸ñÂ÷
Global Left Atrial Appendage Closure Device Market size is anticipated to grow from USD 2.7 Billion in 2024 to USD 13.8 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 19.87% during the forecast period of 2026 to 2033.
The global left atrial appendage (LAA) closure device market is set to experience substantial growth, driven by the increasing prevalence of atrial fibrillation (AF) and the rising demand for effective stroke prevention strategies. LAA closure devices are designed to occlude the left atrial appendage, a common source of thrombus formation in patients with AF, thereby reducing the risk of stroke. As healthcare providers seek to enhance patient outcomes and minimize the complications associated with anticoagulation therapy, the adoption of LAA closure devices is expected to rise significantly, fostering innovation and investment in this specialized market.
Moreover, advancements in device technology and procedural techniques are anticipated to further boost the market. The development of minimally invasive LAA closure devices and improved delivery systems is enhancing the safety and efficacy of the procedure, making it more accessible to a broader patient population. Additionally, the integration of imaging technologies, such as transesophageal echocardiography, is improving procedural guidance and outcomes. As the focus on patient-centered care continues to grow, the demand for innovative LAA closure solutions that offer improved safety profiles and long-term efficacy will continue to rise.
In addition, the increasing emphasis on stroke prevention and awareness of atrial fibrillation is expected to shape the future of the LAA closure device market. As patients become more informed about their treatment options, there is a growing demand for effective solutions that can mitigate the risks associated with AF. Collaborative efforts between medical device manufacturers, cardiologists, and healthcare organizations will be essential in driving these advancements, ensuring that the LAA closure device market remains at the forefront of cardiovascular innovation.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
SEGMENTATION COVERED IN THE REPORT
By Product
- Endocardial LAA devices
- Epicardial LAA devices
By Procedure
By End Use
- Hospitals
- Ambulatory surgical centers
- Others
- COMPANIES PROFILED
- Abbott Laboratories
- AtriCure
- Boston Scientific Corporation
- Lepu Medical Technology
- LifeTech Scientific
- MicroPort Scientific Corporation
- Nanjing YDB Technology
- Shanghai Push Medical Device Technology
- Biosense Webster Inc.
- Aegis Medical Group
- The above list can be customized.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. LEFT ATRIAL APPENDAGE CLOSURE DEVICE INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Procedure
- 3.7.3 Market Attractiveness Analysis By End Use
- 3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET ANALYSIS BY PRODUCT
- 5.1. Overview By Product
- 5.2. Historical and Forecast Data Analysis By Product
- 5.3. Endocardial LAA devices Historic and Forecast Sales By Regions
- 5.4. Epicardial LAA devices Historic and Forecast Sales By Regions
6. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET ANALYSIS BY PROCEDURE
- 6.1. Overview By Procedure
- 6.2. Historical and Forecast Data Analysis By Procedure
- 6.3. Percutaneous Historic and Forecast Sales By Regions
- 6.4. Surgical Historic and Forecast Sales By Regions
7. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET ANALYSIS BY END USE
- 7.1. Overview By End Use
- 7.2. Historical and Forecast Data Analysis By End Use
- 7.3. Hospitals Historic and Forecast Sales By Regions
- 7.4. Ambulatory surgical centers Historic and Forecast Sales By Regions
- 7.5. Others Historic and Forecast Sales By Regions
8. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE LEFT ATRIAL APPENDAGE CLOSURE DEVICE COMPANIES
- 9.1. Left Atrial Appendage Closure Device Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10. COMPANY PROFILES OF LEFT ATRIAL APPENDAGE CLOSURE DEVICE INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Abbott Laboratories
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
- 10.4. AtriCure
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
- 10.5. Boston Scientific Corporation
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
- 10.6. Lepu Medical Technology
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
- 10.7. LifeTech Scientific
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
- 10.8. MicroPort Scientific Corporation
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
- 10.9. Nanjing YDB Technology
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
- 10.10. Shanghai Push Medical Device Technology
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
- 10.11. Biosense Webster Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
- 10.12. Aegis Medical Group
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies
°ü·ÃÀÚ·á